Free Trial

Global Medical REIT (NYSE:GMRE) Sets New 52-Week Low - Should You Sell?

Global Medical REIT logo with Finance background

Global Medical REIT Inc. (NYSE:GMRE - Get Free Report) shares hit a new 52-week low on Friday . The company traded as low as $7.33 and last traded at $7.52, with a volume of 1004388 shares trading hands. The stock had previously closed at $7.63.

Analyst Ratings Changes

Several analysts have recently issued reports on GMRE shares. Berenberg Bank assumed coverage on shares of Global Medical REIT in a research note on Friday, October 18th. They set a "buy" rating and a $11.75 price objective for the company. Alliance Global Partners assumed coverage on Global Medical REIT in a research report on Thursday, September 19th. They set a "buy" rating and a $12.00 price target for the company.

View Our Latest Stock Report on Global Medical REIT

Global Medical REIT Trading Down 1.4 %

The firm's 50 day simple moving average is $8.38 and its 200-day simple moving average is $9.04. The company has a market capitalization of $502.36 million, a PE ratio of -375.81, a P/E/G ratio of 1.46 and a beta of 1.23. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 1.26.

Global Medical REIT (NYSE:GMRE - Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.21 by ($0.18). Global Medical REIT had a return on equity of 0.86% and a net margin of 3.23%. The business had revenue of $34.26 million for the quarter, compared to analysts' expectations of $34.88 million. During the same period last year, the company posted $0.23 earnings per share. As a group, equities research analysts anticipate that Global Medical REIT Inc. will post 0.83 EPS for the current year.

Global Medical REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, January 8th. Investors of record on Friday, December 20th were given a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 11.17%. The ex-dividend date of this dividend was Friday, December 20th. Global Medical REIT's dividend payout ratio (DPR) is presently -4,200.00%.

Hedge Funds Weigh In On Global Medical REIT

A number of institutional investors have recently added to or reduced their stakes in the company. Franklin Resources Inc. boosted its stake in shares of Global Medical REIT by 228.9% during the 3rd quarter. Franklin Resources Inc. now owns 114,988 shares of the company's stock valued at $1,073,000 after buying an additional 80,030 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Global Medical REIT by 158.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 120,614 shares of the company's stock valued at $1,195,000 after acquiring an additional 73,965 shares during the last quarter. Barclays PLC grew its holdings in Global Medical REIT by 87.1% during the 3rd quarter. Barclays PLC now owns 154,051 shares of the company's stock worth $1,527,000 after acquiring an additional 71,704 shares in the last quarter. Duncan Williams Asset Management LLC acquired a new position in Global Medical REIT during the 3rd quarter worth $538,000. Finally, State Street Corp increased its position in shares of Global Medical REIT by 1.5% in the 3rd quarter. State Street Corp now owns 1,924,433 shares of the company's stock worth $19,468,000 after purchasing an additional 28,444 shares during the last quarter. Institutional investors and hedge funds own 57.52% of the company's stock.

Global Medical REIT Company Profile

(Get Free Report)

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Featured Stories

Should You Invest $1,000 in Global Medical REIT Right Now?

Before you consider Global Medical REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.

While Global Medical REIT currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

While 2025 may not deliver massive returns, so MarketBeat analyst Chris Markoch shares his list of seven stocks primed for consistent performance.

Related Videos

NVIDIA Unveils Game-Changing Tech, But Stock Dips
Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?
NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines